INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $210,547 | -11.5% | 5,163 | +21.5% | 0.00% | -40.0% |
| Q3 2022 | $238,000 | +13.9% | 4,250 | +5.2% | 0.01% | +25.0% |
| Q2 2022 | $209,000 | -12.9% | 4,040 | +22.1% | 0.00% | 0.0% |
| Q1 2022 | $240,000 | -38.3% | 3,308 | +0.4% | 0.00% | -33.3% |
| Q4 2021 | $389,000 | -10.8% | 3,294 | +1.4% | 0.01% | -25.0% |
| Q3 2021 | $436,000 | -23.0% | 3,247 | -7.2% | 0.01% | -20.0% |
| Q2 2021 | $566,000 | – | 3,498 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |